JURA Bio, Inc.
PrivateLast Round
Seed
Sep 21, 2023
Total Funding Raised
$16.14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
JURA Bio, Inc. operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in September 2023.
JURA Bio, Inc. is a biotechnology company that develops immune-based therapeutics for autoimmune diseases and oncology by integrating generative machine learning and synthetic biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
JURA Bio, Inc. Comparables
Compare JURA Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nabla Bio | 86% | |
| BigHat Biosciences | 83% | |
| Manifold Bio | 83% |
For institutional investors. Book with your work email.
JURA Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 21, 2023 | ||||
| Grant | Dec 22, 2022 |
For institutional investors. Book with your work email.
JURA Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LabCentral Ignite | Grant |
| Massachusetts Life Sciences Center | Grant |
| Mintz | Grant |
| Fontus Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 80% MoM, reaching 1.6K.
- Dec 22, 2022
$44K grant received from Sanofi and Takeda.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 24, 2026
JURA Bio, Inc. introduced continuous variational synthesis (cVS), a method that enables language-model-style training of variational synthesis models despite discrete chemical constraints, on Sep 24th '26.
For institutional investors. Book with your work email.
JURA Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about JURA Bio, Inc.'s valuation, stock price, and market status.
Is JURA Bio, Inc. a public or private company?
JURA Bio, Inc. is a private company.
What is the current stock price of JURA Bio, Inc.?
JURA Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks JURA Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is JURA Bio, Inc. worth (valuation)?
Valuation information for JURA Bio, Inc. is not publicly available.
Can I buy JURA Bio, Inc. stock?
JURA Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was JURA Bio, Inc.'s last funding round?
JURA Bio, Inc.'s most recent funding round was Seed on September 21, 2023.
Who are the main investors in JURA Bio, Inc.?
Key investors in JURA Bio, Inc. include Fontus Capital.
Will JURA Bio, Inc. IPO soon?
No public IPO plans have been announced for JURA Bio, Inc..
How can I track JURA Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in JURA Bio, Inc.'s shares on secondary markets.